Methods, systems, and computer program products for analyzing and presenting NMR lipoprotein-based risk assessment results
AssigneeLipoScience, Inc.
InventorJames D. Otvos
Life of this patent
Estimating the term…
Loading patent…
AssigneeLipoScience, Inc.
InventorJames D. Otvos
Estimating the term…
A method for analyzing a patient's risk of coronary heart disease by determining the presence of NMR-derived or based lipoprotein constituent value abnormalities includes determining the presence of atherogenic dyslipidemia based on the existence of a clustering of lipoprotein constituent abnormalities as defined by predetermined test criteria. Computer program products and automatically produced reports for presenting NMR-derived lipoprotein risk assessment based on patient-specific lipoprotein subclass results present the measurement results adjacent to a segmented reference risk analysis portion. The actual measured results are visually aligned and enhanced within the risk analysis portion to provide easy reference and understanding of the results relative to a risk of developing coronary heart disease.
A computer program product for automatically generating personalized lipoprotein-based information for a plurality of subjects, the computer program product comprising:
A computer program product for providing patient specific NMR-measured lipoprotein information, the computer program product comprising:
A computer program product for providing patient specific NMR-measured lipoprotein information, the computer program product comprising:
A computer program product for automatically generating personalized lipoprotein-based assessed risk of coronary heart disease information for a plurality of subjects, the computer program product comprising:
A computer program product for automatically generating personalized lipoprotein-based assessed risk of coronary heart disease information for a plurality of subjects, the computer program product comprising:
A computer program product for automatically generating personalized lipoprotein-based assessed risk of coronary heart disease information for a plurality of subjects, the computer program product comprising:
A computer program product for automatically generating personalized lipoprotein-based assessed risk of coronary heart disease information for a plurality of subjects, the computer program product comprising:
A computer program product for automatically generating personalized lipoprotein-based assessed risk of coronary heart disease information for a plurality of subjects, the computer program product comprising:
Dependencies are inferred from the claim text.